共 134 条
[1]
Kattamis A(2022)Thalassaemia Lancet 399 2310-2324
[2]
Kwiatkowski JL(2022)2021 Thalassaemia international federation guidelines for the management of transfusion-dependent thalassemia Hemasphere 6 e732-316
[3]
Aydinok Y(2012)Hematopoietic stem cell transplantation: clinical use and perspectives Biol Res 45 307-391S
[4]
Farmakis D(2021)Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions Blood Rev 48 378S-1887
[5]
Porter J(2004)Therapeutic drug monitoring of cyclosporine: 20 years of progress Transplant Proc 36 1873-492
[6]
Taher A(2021)Factors affecting time-varying clearance of cyclosporine in adult renal transplant recipients: a population pharmacokinetic perspective Pharm Res 38 483-454
[7]
Domenica Cappellini M(2022)Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance J Clin Pharm Ther 47 448-1610
[8]
Angastiniotis M(2014)Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients Am J Med Sci 348 15-575
[9]
Eleftheriou A(2019)Multicenter-based population pharmacokinetic analysis of ciclosporin in hematopoietic stem cell transplantation patients Pharm Res 37 1603-278
[10]
Barriga F(2019)Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation Acta Pharmacol Sin 40 568-545